Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.
Charnwood Team Awards Ceremony Medilink

Share this

The award is very much a reflection of the hard work, talent and commitment of the entire team at Charnwood Molecular.

The company also extends thanks for the ongoing support of its growing client base.

Charnwood Molecular’s exports have grown significantly over recent years, with international clients using Charnwood Molecular’s services towards drug discovery, particularly medicinal chemistry and process research.

Steve Allin, Managing Director of Charnwood Molecular, was delighted with the award: “In the year of our twentieth anniversary as a company, this award is testament to the hard work and commitment of the entire team at Charnwood Molecular. We have seen significant expansion of our global client base in recent years and this recognises our team’s collective efforts in achieving excellence in our services.”

Charnwood Molecular now goes on to the national Medilink awards in the Exports Achievement category.